Steven Murray
Family Medicine · Dalton, OHNPI 1619055886
Payments from drug & device makers
Across 128 payments — averaging $17.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$951
- Pfizer$318
- Novo Nordisk$217
- AbbVie$158
- Johnson & Johnson$129
- GSK$108
- plus $396 from 15 others
What the payments were for
- Food & beverage$2,25499%
- Education$231%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 15 | $951 |
| Pfizer | 35 | $318 |
| Novo Nordisk | 20 | $217 |
| AbbVie(2 entities) | 9 | $158 |
| Johnson & Johnson | 14 | $129 |
| GSK | 8 | $108 |
| Amgen | 4 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $52 |
| Boehringer Ingelheim | 2 | $40 |
| Sanofi-aventis U.S. LLC | 3 | $35 |
| Amarin Pharma, Inc. | 2 | $27 |
| Lilly USA, LLC | 2 | $26 |
| Merck | 2 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Mylan Specialty L.p. | 1 | $19 |
| Vertex | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Avanir Pharmaceuticals, Inc. | 1 | $17 |
| Dexcom, Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Astellas Pharma US Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,277 in reported general payments places this provider in the 75th percentile of 3,983 family medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 144 | $97,677 |
| MounjaroTirzepatide | 80 | $81,967 |
| TrulicityDulaglutide | 47 | $62,146 |
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 13 | $54,709 |
| OzempicSemaglutide | 39 | $50,332 |
| XareltoRivaroxaban | 59 | $46,052 |
| FarxigaDapagliflozin Propanediol | 34 | $39,613 |
| JardianceEmpagliflozin | 41 | $33,299 |
| RybelsusSemaglutide | 13 | $28,419 |
| JanuviaSitagliptin Phosphate | 18 | $18,940 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 13 | $18,496 |
| MovantikNaloxegol Oxalate | 31 | $16,037 |
| JanumetSitagliptin Phos/Metformin Hcl | 31 | $14,453 |
| Tresiba Flextouch U-200Insulin Degludec | 20 | $13,716 |
| Breo ElliptaFluticasone/Vilanterol | 15 | $11,861 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $26 | $144,114127 claims |
| PfizerEliquis | $318 | $97,677144 claims |
| Novo NordiskOzempic, Rybelsus, Levemir | $217 | $84,68565 claims |
| MerckJanuvia, Janumet Xr, Janumet | $26 | $51,88962 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $951 | $50,41358 claims |
| Johnson & JohnsonXarelto | $129 | $46,05259 claims |
| Boehringer IngelheimJardiance, Combivent Respimat | $40 | $39,27754 claims |
| GSKBreo Ellipta, Trelegy Ellipta | $108 | $23,17033 claims |
| AbbVieLinzess | $158 | $7,66513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in Dalton
- Michael ButcherCincinnati$18.3M
- William RandallKettering$7.5M
- Paul NugentCincinnati$4.9M
- Steve ChoiDayton$4.8M
- Martin SchearDayton$2.2M
- Rajesh DavitCincinnati$2M
- Kwabena OtengSpringdale$2M
- Blaise GattoMoraine$1.8M
- Cathy GreiweColumbus$1.4M
- Brian BeesleyColumbus$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.